Literature DB >> 20957524

Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.

Wen-bin Liu1, Ge-liang Xu, Wei-dong Jia, Jian-sheng Li, Jin-liang Ma, Ke Chen, Zhi-hua Wang, Yong-sheng Ge, Wei-hua Ren, Ji-hai Yu, Wei Wang, Xiu-Jun Wang.   

Abstract

Vasculogenic mimicry (VM), including tubular VM and patterned matrix VM, has been generally recognized as a new pattern of tumor neovascularization. Pilot studies of tubular VM showed that it was present in hepatocellular carcinoma (HCC) and associated with poor clinical prognosis. However, whether patterned matrix VM is clinically significant in HCC is unknown. To elucidate the effects of patterned matrix VM on prognosis of HCC and the mechanisms involved in VM formation, we examined 151 cases of surgically resected human HCC by immunohistochemistry and transmission electron microscopy and conducted hypoxic experiments on human HCC cell line MHCC97-H. We observed 31 of 151 (20.5%) cases exhibited evidence of patterned matrix VM. The expression of patterned matrix VM was associated with larger tumors (P = 0.042), vascular invasion (P = 0.016), high-grade HCC (P = 0.022), and late-stage HCC (P = 0.013). Kaplan-Meier survival analysis revealed that cases of the VM group had lower overall survival (OS) rate (P < 0.001) and disease-free survival (DFS) rate (P = 0.002) than that of the non-VM group. Univariate and multivariate analysis indicated that the presence of patterned matrix VM was independent adverse prognostic factor for both OS (P = 0.004) and DFS (P = 0.011). Expression of hypoxia-inducible factor 1 alpha (HIF-1alpha), matrix metalloproteinase (MMP)-2, and MMP-9 were higher in the VM group than in the non-VM group (P = 0.001, P = 0.030, P = 0.007, respectively). After VM formation was induced by hypoxia, up-regulated expression of HIF-1α, MMP-2, and MMP-9 was also detected in cells cultured under hypoxia condition. Our results indicate that patterned matrix VM exists in HCC, and it might serve as an unfavorable prognostic factor for HCC patients. It is possible that hypoxia via induction of expression of HIF-1alpha, MMP-2, and MMP-9 may enhance VM formation in HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957524     DOI: 10.1007/s12032-010-9706-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  39 in total

1.  Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress.

Authors:  Kimiko Yamamoto; Tomono Takahashi; Takayuki Asahara; Norihiko Ohura; Takaaki Sokabe; Akira Kamiya; Joji Ando
Journal:  J Appl Physiol (1985)       Date:  2003-07-11

Review 2.  Angiogenesis and hepatocellular carcinoma.

Authors:  David Semela; Jean-François Dufour
Journal:  J Hepatol       Date:  2004-11       Impact factor: 25.083

3.  Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Authors:  Daisy W J van der Schaft; Femke Hillen; Patrick Pauwels; Dawn A Kirschmann; Karolien Castermans; Mirjam G A Oude Egbrink; Maxine G B Tran; Rafael Sciot; Esther Hauben; Pancras C W Hogendoorn; Olivier Delattre; Patrick H Maxwell; Mary J C Hendrix; Arjan W Griffioen
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

Review 4.  Vasculogenic mimicry: current status and future prospects.

Authors:  Shiwu Zhang; Danfang Zhang; Baocun Sun
Journal:  Cancer Lett       Date:  2007-02-15       Impact factor: 8.679

Review 5.  Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors.

Authors:  M Crowther; N J Brown; E T Bishop; C E Lewis
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

6.  Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.

Authors:  R E Seftor; E A Seftor; N Koshikawa; P S Meltzer; L M Gardner; M Bilban; W G Stetler-Stevenson; V Quaranta; M J Hendrix
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

7.  Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.

Authors:  Jean-Claude Lissitzky; Danielle Parriaux; Elodie Ristorcelli; Alain Vérine; Dominique Lombardo; Patrick Verrando
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

8.  The role of VE-cadherin in osteosarcoma cells.

Authors:  Li-Zhi Zhang; Jiong Mei; Zhi-Kang Qian; Xuan-Song Cai; Yao Jiang; Wei-Da Huang
Journal:  Pathol Oncol Res       Date:  2009-09-17       Impact factor: 3.201

9.  Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model.

Authors:  Evelyne Dupuy; Patricia Hainaud; Aude Villemain; Eva Bodevin-Phèdre; Jean Philippe Brouland; Pascale Briand; Gérard Tobelem
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

10.  Vasculogenic mimicry of acute leukemic bone marrow stromal cells.

Authors:  P Mirshahi; A Rafii; L Vincent; A Berthaut; R Varin; G Kalantar; C Marzac; O A Calandini; J-P Marie; C Soria; J Soria; M Mirshahi
Journal:  Leukemia       Date:  2009-04-02       Impact factor: 11.528

View more
  34 in total

1.  Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.

Authors:  Da-Min Chai; Zheng-Qi Bao; Jian-Guo Hu; Li Ma; Zhen-Zhong Feng; Yi-Sheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.

Authors:  Yanzi Qin; Wenjun Zhao; Lili Cheng; Shiwu Wu; Qiong Wu; Jin Gao; Zhaonan Bian; Li Ma
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

3.  Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.

Authors:  Anastasia R Aikins; MiJung Kim; Bernardo Raymundo; Chan-Wha Kim
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-06

Review 4.  Histochemical Staining of Vasculogenic Mimicry.

Authors:  Saber Imani; Shuya Liu; Mazaher Maghsoudloo; QingLian Wen
Journal:  Methods Mol Biol       Date:  2022

5.  MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A.

Authors:  Bin Huang; Enhua Xiao; Manping Huang
Journal:  Med Oncol       Date:  2014-12-09       Impact factor: 3.064

6.  Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway.

Authors:  Wenchen Gong; Baocun Sun; Xiulan Zhao; Danfang Zhang; Junying Sun; Tieju Liu; Qiang Gu; Xueyi Dong; Fang Liu; Yong Wang; Xian Lin; Yanlei Li
Journal:  Oncotarget       Date:  2016-10-25

7.  miR-1236 down-regulates alpha-fetoprotein, thus causing PTEN accumulation, which inhibits the PI3K/Akt pathway and malignant phenotype in hepatoma cells.

Authors:  Rui Gao; Chunli Cai; Jiancheng Gan; Xi Yang; Zeyu Shuang; Min Liu; Shengping Li; Hua Tang
Journal:  Oncotarget       Date:  2015-03-20

Review 8.  Advanced research on vasculogenic mimicry in cancer.

Authors:  Lili Qiao; Ning Liang; Jiandong Zhang; Jian Xie; Fengjun Liu; Deguo Xu; Xinshuang Yu; Yuan Tian
Journal:  J Cell Mol Med       Date:  2015-01-19       Impact factor: 5.310

9.  Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.

Authors:  Lin Wang; Li Lin; Xi Chen; Li Sun; Yulin Liao; Na Huang; Wangjun Liao
Journal:  Oncotarget       Date:  2015-05-10

10.  Overexpression of Wnt5a promotes angiogenesis in NSCLC.

Authors:  Lingli Yao; Baocun Sun; Xiulan Zhao; Xueming Zhao; Qiang Gu; Xueyi Dong; Yanjun Zheng; Junying Sun; Runfen Cheng; Hong Qi; Jindan An
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.